Penn Gynocologic Oncology Care Newsletter
 

Winter 2007

Answers to Your Questions about Cervical Cancer
Do You Need an HPV Test?
Now Available: The HPV Vaccine
HPV Vaccine - A New Direction in Cancer Prevention
 
Care Pages
 

Information You Should Know About the Human Papilloma Virus (HPV) Vaccine

The Human Papilloma Virus (HPV), is one of the most common sexually transmitted diseases (STD). With over 6.2 million new cases diagnosed each year, HPV is the leading cause of cervical cancer. HPV affects approximately 80 percent of all adults by the time they reach age 50.

Christina Chu, MD, an assistant professor in the Division of Gynecologic Oncology at the University of Pennsylvania Health System states: “HPV is a general name for a group of viruses that include more than 100 different strains. About 20 percent of women infected with HPV will develop chronic infection, and of these, about 2 percent will develop cervical cancer. Researchers have determined that HPV is found in almost 100 percent of cervical cancers worldwide.”

HPV Vaccine Now Available
On June 8, 2006, the Food and Drug Administration (FDA) licensed the first vaccine developed to prevent cervical cancer and other diseases in females caused by certain types of HPV. On June 29, 2006, the Advisory Committee on Immunization Practices voted to recommend use of the HPV vaccine in females ages 9 to 26 years old.

Facts about the HPV Vaccine:

  • HPV vaccine can prevent cervical cancer. An estimated 9,710 new cases of cervical cancer will occur in 2006 and about 3,700 women will die.
  • To be most effective, the vaccine should be administered before the onset of sexual activity. However, females who are sexually active may also benefit from the vaccination.
  • HPV vaccines will not eliminate all HPV infections or all cases of cervical cancer but they do prevent HPV types that cause 70 percent of cervical cancer cases.
  • Both vaccines appear to be safe and well tolerated; the most common side effect has been soreness at the injection site.
  • HPV vaccines will not prevent infection related to other sexually transmitted diseases and it will not eliminate the need for cervical cancer screenings (Pap smears).
  • Because the vaccine is very new, the length of vaccine protection is unclear. Current studies indicate that the vaccine is effective for at least five years.
  • The vaccine does not cure HPV if a female has already contracted the virus.
  • The majority of doctors intend to recommend HPV vaccinations for children and young adults. Parental acceptance is also high, especially after parents are educated about HPV and cervical cancer.

It is important to talk to your health care provider about the HPV vaccine especially if you are under the age of 26 or if you have children between the ages of 9 and 26. In addition, you should also contact your insurance company to determine if the vaccine is covered by your health policy.

 


 

Need an appointment? Request one online 24 hours/day, 7 days/week or call 800-789-PENN (7366) to speak to a referral counselor.

Related Links
Find an Ob/Gyn
Request an Appointment Online or call
1-800-789-PENN (7366)
Penn Ob/Gyn Care:
Gynecologic Oncology
Visitor Information
Penn Gynecologic Cancers Newsletter

-

Current Issue

-

Archive

-

Subscribe Today!
RSS feed Newsletter RSS Feed
 
Penn Ob/Gyn Care Newsletters

Gynecologic Oncology

Pregnancy & Parenting

Women's Health

 

   
   

 

About UPHS   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

The University of Pennsylvania Health System, Philadelphia, PA 800-789-PENN © 2008, The Trustees of the University of Pennsylvania